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ABSTRACT
LOGAN H. RAMSEY: Patient perceptions of medication therapy management targeted
for adherence following the provision of influenza immunizations by student
pharmacists: Preliminary findings
(Under the direction of Ashley W. Ellis)
Objective: To examine patients’ opinions of clinical pharmacy services, especially
Medication Therapy Management (MTM), following the administration of influenza
immunization.
Methods: The McLean Institute for Public Service and Community Engagement at the
University of Mississippi funded a service-learning project for student pharmacists to
administer influenza immunizations to medically underserved patients. The project was
conducted at a clinic for uninsured patients in Southaven, Mississippi but was open to the
public. Patients (n=52) received an influenza immunization followed by a personal
medication record during the observation period. Students, under the supervision of a
licensed pharmacist, then provided a medication review and Drug Adherence Work-Up
(DRAW) to identify adherence problems. A survey was administered to patients
regarding services received. Demographics and beliefs on pharmacists’ roles were also
assessed.
Results: 30% of the sample reported a household income below $15,000 and 33% lacked
health insurance. However, most patients attempt to obtain a flu shot every year (M=4.22;
Likert scale 1 to 5). 97% indicated trust in pharmacists’ abilities as clinical providers.
63% of patients (n=33) reported taking 1 or more prescription medications daily, with a
mean number of 3.6 medications. Medication adherence problems were identified in
approximately half (49%) of patients. Respondents noted “forgetting” as the primary
relevant issue. Two-thirds of patients (65%) were not aware of pharmacist-provided
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MTM. Overall, 80% of patients found the combined immunization and MTM a beneficial
service (M=4.38; Likert scale 1 to 5). 74% would visit a community pharmacy to receive
further MTM services in the future.
Conclusions: While survey results indicate low awareness of MTM, a significant number
of patients experienced medication adherence issues. Pharmacy visits for annual
influenza immunizations may provide an excellent opportunity for pharmacists to
implement the model in this study and provide MTM or adherence services.
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CHAPTER I
Introduction
History of Vaccination
As civilizations developed, the human race made the shift towards centralized
agrarian societies, and pathogens evolved to spread illness from one human to the next.1
Living in close proximity and sharing water supplies within cities increased the severity
of infectious viruses and bacteria to “epidemic” levels.1 One such epidemic included the
debilitating and highly lethal Variola major virus, more commonly known as smallpox.
At one point, fatality rates for smallpox rose to 60% in adult victims and 80% within
infected infants.2 By the 18th century, smallpox related illness caused 400,000 deaths in
Europe every year.2
Fortunately, Edward Jenner – an English physician and scientist – conceived an
idea to cure this infectious disease in 1796.2 Jenner chose to deliberately infect a patient
with the cowpox virus.2 After experiencing a mild form of cowpox illness, the patient
recovered within the span of a week. A few months later, Jenner exposed the patient to
the live, active smallpox virus. As Jenner hypothesized, the young male showed
resistance to the virus and did not develop any symptoms of the smallpox disease.2 Thus,
the preventative health service of immunization was invented.
Approximately two centuries after Jenner’s investigation, all known cases of the
smallpox disease were eliminated in 1977 through the implementation of universal
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vaccination.3 Despite eradication of smallpox, however, the battle against infectious
diseases is far from won. In particular, the influenza virus causes serious illness and even
death every year. The Centers for Disease Control and Prevention notes that annual
influenza vaccinations are especially important for protecting those at risk for
complications, such as elderly patients, young children, and pregnant women.4 Based on
data from 2012-2013, seasonal flu vaccination coverage in the United States averaged
56% for children and 42% for adults with 73,130 collected specimens positive for
infection with influenza virus.5-6

History of American Pharmacy
While medical advancements such as vaccinations moved forward, the profession
of pharmacy developed concurrently. By the early 1700s in New England, a substantial
amount of “apothecary shops” started up in communities and provided numerous plantbased medications to patients.7-8 In the year 1752, Jonathan Roberts became the first
dedicated apothecary at the nation’s earliest hospital in Pennsylvania.7 The expanding
responsibilities of the apothecary set the precedent for two primary roles in modern day
pharmaceutical care: community pharmacy and institutional pharmacy.
Following the conclusion of the Revolutionary War, apothecaries and druggists
started working with numerous chemicals for their medicines including sulfuric acid, a
chemical still commonly used for pharmaceutical purposes today.7 In 1821, the
foundation of the Philadelphia College of Pharmacy provided the first professional school
of instruction for pharmacists.7-8 The profession of pharmacy became more distinct and
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separate from medicine with the establishment of the American Pharmaceutical
Association (APhA) in 1852.7
The University of Mississippi, recognizing the need for pharmacy education,
established the state’s first and only School of Pharmacy on September 24, 1908.9 The
initial School of Pharmacy consisted of seven faculty members and only 15 students.9
After 108 years of growth, the School of Pharmacy currently includes 114 faculty
members and over 350 professional students striving to advance the profession of
pharmacy.

Modern Roles of the Pharmacist
As modern health care providers, pharmacists are critical for maintaining public
health and wellness. Combining medical and professional skills with the knowledge of
immunization procedures, pharmacists can act as powerful advocates for preventative
health care measures such as immunizations. As part of the continued endeavor to
increase influenza vaccination rates, community pharmacists who receive the appropriate
training are uniquely placed to intervene and provide clinical immunization services.10
Below average access to primary care remains a significant barrier for
underserved patients especially in rural locations. According to the Mississippi State
Department of Health, 75 out of 82 counties in Mississippi are currently designated as
Health Professional Shortage Areas (HPSA).11 Pharmacists are in a position to fill the
primary care gap with clinical services such as immunizations and Medication Therapy
Management (MTM). Medication Therapy Management includes clinical services such
as disease state management, Medication Therapy Reviews, and medication plans
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focusing on adherence and safety.12 Pharmacists are among the most accessible members
of the health care team. According to The National Association of Chain Drug Stores, the
majority of Americans (93%) live within 5 miles of a community pharmacy, and the
average distance to a retail pharmacy is only 1.26 miles.13 Patients are able to visit retail
pharmacies without an appointment and receive counseling for their medication related
problems. Patients can also seek readily available immunization services in all 50 states.14
More than 150,000 pharmacists have undergone training to administer many
immunizations including the annually recommended influenza shot.14 As stated by the
Centers for Disease Control (CDC), between 5 and 20 percent of the United States
population becomes infected with the influenza virus annually.14 Throughout the past 3
decades, influenza related deaths have ranged from 3,000 to 49,000 each year.14 Patients
who decide to receive the influenza vaccine can benefit financially through decreased
visits to the doctor and less time off work. More importantly, immunizations can prevent
unnecessary death caused by the influenza virus and associated secondary illness such as
pneumonia.
In addition, best practices indicate “vaccine providers…should consider observing
patients (with patients seated or lying down) for 15 minutes after vaccination to decrease
the risk for injury.”15 Pharmacists can use the suggested 15 minute waiting period after
providing an influenza vaccine to engage the patient in further clinical services, such as
Medication Therapy Management including a Personal Medication Record (PMR).16
While MTM is generally provided during a scheduled appointment, MTM services may
be provided for walk-in patients, similarly to the provision of influenza immunizations.16
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The overall focus in MTM shifts from simply dispensing the prescription to providing
patient-based care through clinical pharmacy services.16
Another important aspect of MTM includes the chance to assess and improve
patients’ medication adherence. According to the Network for Excellence in Health
Innovation, as many as 2 billion occurrences of medication non-adherence are
preventable annually.17 As a result, $290 billion in health care costs is wasted every year
due to medication non-adherence.17 While medications have the potential to effectively
treat a multitude of problems, approximately 50% of patients do not correctly take their
medications.17 Though taking a prescription medication might appear simple enough,
Brown and Bussell explored the nature of medication adherence and found the issues
“extremely complex.”18
Brown and Bussell also point out that treating medication adherence requires an
individualized approach because each patient has different issues and behaviors.18
Assessment of adherence comes from two primary sources. Subjective information may
be uncovered by directly questioning the patient, patient’s family, and physicians.18
Objective information is obtained from counting pills, checking the number of pharmacy
refills, and using electronic medication monitoring systems.18 Pharmacists have the
ability to directly monitor medications dispensed while also providing individualized
adherence management through engaging the patient in MTM services.

Mississippi Delta and Health Disparities
The lack of proper medication adherence results in decreased overall health
outcomes and increased patient mortality.18 Potential causes that lead to lower levels of
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adherence include several patient based factors. Significant reasons underlying nonadherence include “lack of understanding their disease, lack of involvement in the
decision making process, and suboptimal medical literacy.”18 Approximately 90 million
people in the United States have medical literacy that is deemed inadequate.19 Examples
of low health literacy include inability to interpret a prescription drug bottle label, not
understanding medical education brochures, confusion regarding doctor's directions and
consent forms, and difficulty negotiating complex health care decisions.20
The correlation between low medical literacy and health disparities continues to
be explored, especially in areas of economic poverty. Zoellner et al. reported that 64% of
residents in the Mississippi Delta function at the lowest tiers of literary capability.21 The
population within the Mississippi Delta consists of a higher than average percentage of
African Americans and increased prevalence of chronic diseases such as diabetes and
cardiovascular disease.21 Zoellner et al. conclude, “Mississippi is one of the most health
disparate regions in the United States.”21
According to Cossman, only 12% of the primary care physicians working in
Mississippi are practicing in the Delta, although almost 20% of the state’s population
resides in this region.22 The lack of providers in the Delta creates even more barriers to
access for primary care services. As health care professionals search for new methods to
combat the health disparities present in Mississippi, pharmacists are available as highly
accessible and trusted sources of health management.
The roles required of pharmacists have changed greatly over time, from
apothecary dispensing functions to modern clinical provider. As the practice of pharmacy
continues to change within the health care system, utmost importance remains centered
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on the oath that every pharmacist takes to “apply knowledge, experience, and skills to the
best of my ability to assure optimal outcomes for my patients.” Pharmacists have the
ability to step in and fill the primary care gap present in underserved areas. This study is
important in the field of pharmacy practice because it seeks information on ways
pharmacists can impact and improve the lives of patients they serve. In particular, this
study investigates the possibility of using clinical services, such as immunizations, to
further engage with patients and uncover more serious medication issues, including nonadherence.
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CHAPTER II
Literature Review
Previous research studies have considered both pharmacist-provided
immunizations and medication therapy management. Numerous studies have inquired
about patient perceptions on clinical pharmacy services including MTM.23-27 However,
studies have rarely focused on MTM targeted towards underserved areas such as the
Mississippi Delta. Few to none have considered patient opinions regarding conjointly
provided MTM and immunization services.

Pharmacist Provision of Influenza Immunizations
Pharmacists initially began the administration of immunizations as part of
standard community practice in 1994.28 By 2002, less than a decade later, the American
College of Physicians and American Society of Internal Medicine announced official
endorsement of pharmacist-provided immunizations.29 In a 2012 publication, Murphy et
al. evaluated the amount of pharmacist-provided immunizations at Walgreen’s
community pharmacies in medically underserved areas (MUAs).29 Based on their
findings, 43% of the United States population (132 million people) lives in areas
designated as “medically underserved” with below average access to primary care
services.29 The highest amount of MUAs (78%) was found within the state of
Mississippi.29
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The current state of health care in the United States, specifically within
Mississippi, requires serious attention. When almost 80% of the state does not have
adequate access to primary care, the costs associated with treating chronic diseases such
as diabetes and cardiovascular disease (CVD) will inevitably rise. The lack of access to
preventive health services such as immunizations creates further problems. When too few
people receive the influenza immunization, herd immunity cannot be achieved. Herd
immunity is defined as “the resistance of a group to attack by a disease because of the
immunity of a large proportion of the members…so not everyone in a population needs to
be immunized to eliminate disease.”30 Thus, fewer patients obtaining immunizations in
Mississippi will result in more of the population contracting the influenza virus.
Through the use of community pharmacists as immunization providers,
Walgreen’s pharmacies in the study by Murphy et al. supplied influenza vaccinations to
33,951 patients in MUAs in Mississippi.29 Steyer et al. concur with the information
obtained through the Walgreen’s study by determining pharmacists have the ability to
substantially increase the amount of patients who can obtain and receive the influenza
immunization each year.31
Though pharmacists can offer better availability and access to immunizations, the
perception and willingness of patients to utilize this service must also be considered.
Based on data from the Department of Health and Human Services, only 26% of children
between the ages of 5 and 12 received the influenza vaccine in 2008.32 Pharmacists have
the opportunity to educate parents about vaccination benefits for children and increase the
rates of immunization among young age groups.
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A cross-sectional descriptive study conducted by Deshpande et al. questioned
parents regarding pharmacist provision of the influenza vaccine to their children. This
study further supported the accessibility of pharmacists as immunization providers: 98%
of parents stated their child received the vaccination without making a prior
appointment.10 Approximately 3 out of 4 parents indicated the desire to utilize a
pharmacy again for their child’s influenza shot next year.10 The results from the study
conducted by Deshpande et al. are consistent with similar studies, such as Grabenstein,
Guess, and Hartzema’s finding that “respondents vaccinated by a community pharmacists
were satisfied with the experience and would recommend it to others.”33

Medication Therapy Management
After almost 20 years of routinely provided immunizations by pharmacists, many
patients are prepared to accept pharmacists as an available and trusted source for
vaccination services. However, newly developed clinical pharmacy services are also
becoming prevalent in community pharmacy settings. In particular, medication therapy
management as a pharmacy practice service model could enable pharmacists to provide
more extensive care for patients.
Lemay notes that, with the busy atmosphere common for many pharmacies, MTM
offers the pharmacist direct, undisturbed communication with their patient.34 For
pharmacists wishing to implement MTM services in their practice, the American
Pharmacists Association (APhA) and the National Association of Chain Drug Stores
(NACDS) determined the five core elements needed in an MTM service model (Table 1).
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Table 1: Core Elements of Medication Therapy Management
1

Comprehensive Medication Review (CMR)

2

Personal Medication Record (PMR)

3

Medication-related Action Plan (MAP)

4

Intervention and/or referral

5

Documentation and follow-up
Source: Lemay, Ginger. “Medication Therapy Management in Community Pharmacy Practice.”
Medicine and health, Rhode Island 95.9 01 Sep 2012: 281. Rhode Island Medical Society, 2013.

CMR appears as the first and most prominent feature of MTM. When performing
a CMR, the pharmacist should review the patient’s current medications, both prescription
and over-the counter, with the goal of improving the drug therapy outcome.16,34 The
pharmacist then begins the PMR including information such as the patient’s name, date
of birth, emergency contact, primary physician, allergies, and current medications the
patient is taking.16 After looking for potential drug therapy problems (DTPs), the next
step for the pharmacist includes suggesting solutions to any problems uncovered via the
MAP.34 The patient may then utilize the MAP in future visits with his or her physician.
Both PMR and MAP should be updated as often as possible to reflect changes in the
patient’s drug therapy.34
Upon completing the first 3 steps, the pharmacist may choose an intervention by
communicating directly with the patient about DTPs and adherence or by contacting
fellow health care providers such as the patient’s physician.16 In some instances, the
pharmacist might refer a patient to a particular health professional. For example, the
pharmacist could send a patient with type II diabetes mellitus to meet with a dietician.
Finally, a pharmacist should thoroughly document the patient care services completed
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during the MTM session. Proper documentation allows the patient’s physician to
understand the pharmacist’s recommendations, upholds professional accountability for
the pharmacist, and further supports the value placed on pharmacist-provided MTM.16
Previous investigations have sought patient preferences regarding MTM services
provided to Medicare Part D beneficiaries. According to data gathered by Hong et al.,
Medicare beneficiaries in Memphis, TN cited the associated cost with MTM as their
greatest consideration.23 Another primary concern was choosing the optimal practice
setting for MTM services. Participants in the study valued MTM services provided by
pharmacists in face-to-face encounters over alternative settings such as via telephone or
at their home.23 Participants reacted most favorably to MTM sessions lasting
approximately 15 minutes.23 This indication in patient preferences suggests that
pharmacists can use the short time period after immunizations, around 15 minutes, to
offer medication therapy management to patients visiting a community pharmacy.
Lauffenburger et al. conducted qualitative investigations to uncover themes in
patient preferences and opinions on MTM. When considering experiences receiving
MTM, the primarily older adult participants recited the following benefits of MTM:
comprehensive personalized care, medication review to increase effectiveness of
medications, and interceding with health plans.25 As previously reported Hong et al.,
participants in the study by Lauffenburger also cited cost of MTM as the most prominent
barrier to receiving the service.25 In rural, medically underserved areas like Mississippi,
pharmacists must be especially sensitive to how the cost of MTM might affect the
patient’s willingness to obtain clinical pharmacy services. An important goal for

!

12!

improving MTM accessibility should include finding ways to make MTM an affordable
service while maintaining financial viability for the pharmacist.

MTM and Health Disparities
MTM shows promise for increasing patient adherence levels, but MTM also
allows the pharmacist opportunity to improve disease state management for chronic
illnesses like diabetes. Only a few studies have examined the effect of MTM on
underserved and minority patients. Congdon et al. evaluated the effect of MTM on
diabetic, underserved Hispanic patients by checking their glycated hemoglobin levels,
commonly known as A1C.35 For patients with A1C values below 9%, there was small
change in hemoglobin levels post-MTM services.35 However, for patients with A1C
above 9%, the majority of patients (94%) show significant decrease in A1C levels
averaging from 10.9% down to 8.8%.35
While a single MTM visit did not produce significant changes in A1C levels,
patients who return to obtain multiple MTM visits also showed a significant decline in
A1C.35 The trend suggested a correlation between increased MTM visits and better
disease management of diabetes.35 When providing immunization services, pharmacists
can use the opportunity to initiate an MTM encounter. However, scheduling follow-up
MTM services appears important for substantial impact on diabetes management.
Taylor, Byrd, and Krueger also studied the effect of pharmacy services on patients
with hypertension, diabetes, dyslipidemia, and anticoagulation therapy. Taylor, Byrd, and
Krueger also targeted underserved patients; however this study took place in rural
Alabama. The intervention in this study included MTM-style medication reviews, disease
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education, and patient training for inhalers, glucometers, and pill boxes.36 After 12
months of intervention services, the patients displayed significantly improved control of
hypertension, hemoglobin A1C, and LDL cholesterol levels.36 It is also worth noting that
medication adherence scores in the intervention group increased by 15%.36 Clearly,
clinical pharmacy practice services have the capability to dramatically improve health
outcomes and management of disease states, even specifically in disadvantaged
populations.
The topic of health disparities is especially important when considering the
Mississippi Delta, which has double the national poverty rate and a 38% obesity rate.37
The poverty and obesity are undoubtedly factors in the very high incidence of diabetes
found in the Delta. Ross and Bloodworth conducted research at 13 community
pharmacies in a total of nine Delta counties to study the impact of a patient-centered
health care model (PCHC) on rural communities.37 Initially, the Delta Pharmacy Project
study only included Medicaid beneficiaries between 18 and 64 but expanded to include
all patients over the age of 18 years old. The PCHC was strongly based on both
specialized and general MTM services. Pharmacists engaged the patients with face-toface MTM services, including CMR, and followed the core elements set out by the
APhA.37 In total, 468 patients joined the MTM program supported by the Delta Pharmacy
Project over a period of 2 years.37
Specific to medication adherence, the Delta Pharmacy Project discovered nonadherence issues in 58% of patients.37 The study also measured blood pressure,
cholesterol levels, and A1C with significant decreases observed over time on these
measures.37 From an economic standpoint, the MTM interventions reduced costs by
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decreasing emergency room visits, hospitalizations, and physician appointments for
patients.37 The Delta Pharmacy Project further validated the apparent health care
problems and disparities present in the Mississippi Delta. While this is preliminary data,
the research conducted by Ross and Bloodworth also confirmed the ability of pharmacists
to positively influence health outcomes in rural Mississippi.37 The study did not,
however, inquire about patient perceptions regarding the MTM services received at the
community pharmacies.
The clinical and financial findings by Ross and Bloodworth concur with a
previous experimental, longitudinal pre-post study on MTM outcomes known as The
Asheville Project. This research project by Bunting and Cranor considered the following
measurements of health status: blood pressure (systolic and diastolic) and cholesterol
(LDL and total).38 For both of these measurements, the improvement in patient health
status was statistically significant over the 5-year duration of the MTM study.38 The
patient’s improved health status was reflected in a significantly decreased amount of
cardiovascular (CV) events among the cohort.38 The definition of CV events included
“myocardial infarctions (MIs), non-MI acute coronary syndromes (ACSs), strokes,
transient ischemic attacks (TIAs), acute episodes of heart failure (HF), coronary artery
bypass grafts (CABGs), percutaneous transluminal coronary angioplasty (PTCA), and
peripheral vascular disease (PVD).”38
Once again, the potential for MTM clinical services to improve health status was
demonstrated in this research. The improvements following clinical pharmacy service
programs are measurable and significant. The effect of targeting such clinical pharmacy
services towards underserved populations requires further research consideration.
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MTM and Pharmaceutical Education
While clinical community pharmacists innovate and incorporate MTM into the
practice settings, pharmacy educators must also consider how courses in pharmacy school
affect students’ ability to practice MTM. Galal et al. implemented a Medicare Part D
elective course for 33 second-year (PY2) pharmacy students at the Thomas J. Long
School of Pharmacy and Health Sciences. The focus of the study was measuring student
pharmacists’ confidence and ability to provide MTM and influenza immunizations.39
88% of the students entering the class did not have previous experience with MTM
provision, and 64% did not have experience in administering immunizations.39 After
assisting 401 Medicare beneficiaries during 9 events, the student pharmacists’ show
significant increases in confidence ratings for provision of both immunizations and
MTM.39 Qualitative results from the students included that the course was “challenging
but rewarding, eye-opening, and inspiring.” Students also found that applying knowledge
from the course to patient care settings was a substantial benefit.39
Student pharmacists who gain confidence in providing MTM and immunizations
are better equipped to integrate clinical pharmacy practice services upon graduation.
Pharmacy faculty and educators can consider the importance of implementing such
courses within professional pharmacy degree programs.

Summary
After a thorough evaluation of the scientific literature relating to medication
therapy management, pharmacist provision of immunizations, and the impact of MTM on
health disparities, pharmacists are in a prime position to provide clinical services and
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improve health outcomes for patients. The literature also strongly suggests that the
benefits of MTM and immunizations are both tangible and significant. However, the
sufficient literature does not exist that considers patient perceptions and beliefs on the
value of these services when provided in rural locations. The goal of this thesis is to
examine the participants’ thoughts and opinions, particular when located in a region of
disadvantaged economic and health status.
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Chapter III
Research Methodology
Research Design
The overall design of the study conducted for this thesis was exploratory and
descriptive. In particular, the study sought to explore the patient perceptions of conjointly
provided influenza immunizations and Medication Therapy Management targeted for
adherence. Thus, it was determined that patients in the study should receive a clinical
pharmacy intervention prior to the survey assessment. Second year (PY2) student
pharmacists from the University of Mississippi School of Pharmacy provided the services
as part of a service-learning grant from the McLean Institute for Public Service for
Community Engagement. Funding from the McLean Institute allowed for provision of
free influenza immunizations and associated supplies. Further financial support for the
project came from the Sally McDonnell Barksdale Honors College.
The intervention began with a free influenza immunization at a clinic designated
for uninsured patients in Desoto County, specifically located in Southaven, MS. Patients
not taking any medications did not undergo MTM and simply completed a partial survey.
However, for each patient taking prescription medications, the student pharmacists (under
the supervision of a licensed pharmacist) engaged the patients in a medication review and
provided a Personalized Medication Record (PMR) during the waiting period following
immunization. Next, students administered the Drug Adherence Work-Up Tool (DRAW
tool) provided by the Million Hearts® Initiative through the U.S. Department of Health
!
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and Humans Services to identify any existing adherence issues for the patients. After the
DRAW tool was completed, student pharmacists provided adherence-focused MTM
services. Finally, patients completed a survey designed to assess perceptions regarding
the services received during the event. Pharmacy faculty members and residents provided
oversight and guidance during the event if students had any questions or problems
providing the services. The project flow chart (Appendix B) provides a visual
representation of the project.
The instrument used to measure patients’ opinions and perceptions was a paperbased survey provided in person. The patients completed the survey, which was approved
by the Institutional Review Board at the University of Mississippi. Research emphasis
was placed on the following objectives:
1) Determine patient perceptions of the roles of pharmacists, including trust in
pharmacists as clinical providers.
2) Determine patients’ awareness of MTM.
3) Determine patients’ perceived benefit and satisfaction from the MTM services
received during the intervention.
4) Compare patients’ non-adherence with MTM helpfulness.
5) Compare patients’ self-reported non-adherence with DRAW tool results.

Survey Development
The survey used in this study was designed to assess patients’ perceptions after
receiving the clinical pharmacy services from student pharmacists. Because of the
difficulty associated with obtaining follow-up surveys, especially without incentives, the
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survey was administered immediately at the time of the intervention. According to Nulty,
paper-based surveys provided substantially higher response rates than other formats. In
particular, paper-based surveys gather stronger response rates than surveys sent out
online.40
The survey used in this project (Appendix A) contained 25 items total. Many
questions utilized the dichotomous measure of “yes” or “no.” The initial portion of the
survey included nine questions focused on medication use and perceptions of
pharmacists’ roles, with one open-ended qualitative measure. The next section provided a
description of Medication Therapy Management to clarify the topic for patients. The
following nine questions inquired about the MTM intervention, including another openended qualitative measure. Five of the MTM questions obtained Likert-type responses on
a scale of 1 to 5 (strongly disagree to strongly agree). Two questions were related to flu
immunizations. Finally, the survey included a section of five questions on demographic
information.
The survey included measures adapted from a survey administered by Law,
Okamoto, and Brock.24 Permission to use and modify the questions was obtained by
contacting the principal investigator, Anandi V. Law, BPharm, PhD. Several faculty
members and one resident at the University of Mississippi School of Pharmacy also
reviewed the survey, providing further validation.
Questions regarding demographics were placed at the end of the survey for two
purposes: first, because patients were screened based on prescription medication use
rather than demographic information, and secondly to procure responses to the more
important questions on adherence and MTM before patients became weary with the
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survey. The survey endeavored to maintain an appropriate logical flow by beginning with
questions on medication use and pharmacists’ roles before moving to questions about the
MTM services.

Drug Adherence Work-Up Tool
For the purposes of assessing adherence, a cohesive and streamlined tool is
essential for use in a community pharmacy practice setting. Doucette et al. developed the
Drug Adherence Work-up Tool (DRAW) for use during pharmacist-provided MTM,
specifically targeted for adherence.40 After implementing the tool, pharmacists in the
study affirmed that using DRAW enabled better identification and resolution of
medication adherence issues.40 DRAW considers the following factors affecting
medication adherence: too many drugs or doses, forgetfulness, concern about medication,
belief in medication effectiveness, medication costs and adverse effects.40 When
attempting to provide MTM during an immunization visit, pharmacists can utilize
DRAW as a streamlined method, especially in situations where adherence problems are
suspected.

Data Collection
The sample used in this study was collected during October and November of
2013 at Desoto Health and Wellness Center in Southaven, MS. This location was deemed
appropriate because of the underserved population targeted. According to the U.S.
Department of Health and Humans Services, Southaven is designated as a medically
underserved area of the state. While the clinic serves uninsured patients, the service event
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was open and advertised to the public. With funding from the Sally McDonnell Barksdale
Honors College, radio advertisements (Appendix C) went out on the air during the week
prior to the event. The radio stations included IDIA-AM, WDIA-AM, and WEBL-FM.
The purpose of radio advertising was to recruit a higher number of participants. Based on
the RAOSOFT Sample Size Calculator, for a margin of error set at 10% and a 90%
confidence level, the recommended sample size is 68. The McLean grant provided a total
of 90 influenza immunization shots. The minimal risks to patients included soreness,
redness, swelling, low-grade fever, and aches, as stated by the Centers for Disease
Control and Prevention.
The primary selection criteria applied to patients was the use of prescription
medications. Those who did not take prescription medications were not eligible to
participate in MTM services. Before offering the survey to patients, student pharmacists
followed a script (Appendix D) inquiring about willingness to participate in the study and
required a minimum age of 18 years old. Following the survey, patients placed completed
surveys in a confidential envelope.

Data Analysis
Following the final collection of surveys, data was coded numerically and directly
entered in Microsoft Excel. For example, “yes” responses designated as the number 1,
and “no” responses designated as the number 2. While all surveys collected did not
include personal identifiable information, each survey and DRAW tool was labeled with
a unique number. This facilitated the correct matching between surveys and DRAW tool
results. Data was imported into IBM SPSS Statistics for Macintosh, Version 21. Only
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questions from patients taking prescription medications were used for analysis of
questions regarding MTM services.
The survey provided descriptive and qualitative information about patients’
opinions to assess Objectives 1, 2, and 3. The Likert-type questions offered descriptive
ordinal data for ranking patients’ agreement or disagreement on a scale from 1 to 5
(strongly disagree to strongly agree. According to Sullivan and Artino, “the differences
between ‘always,’ ‘often,’ and ‘sometimes’ on a frequency response Likert scale are not
necessarily equal. In other words, one cannot assume that the difference between
responses is equidistant even though the numbers assigned to those responses are.”42
Thus, the use of parametric tests (t-tests, analysis of variance, Pearson correlations,
regression, etc.) was avoided in the analysis of Likert-type responses. Descriptive
statistics such as means, medians, standard deviations, frequencies, and percentages was
deemed more appropriate for analysis of Likert data.
For Objective 4, the data on self reported non-adherence and MTM helpfulness
was analyzed with a Fisher’s Exact test with 2x2 contingency table. For Objective 5,
dichotomous survey questions were grouped by DRAW tool response and self reported
non-adherence for paired nominal data analysis with McNemar’s test. A α-priori of 0.05
was chosen to indicate statistical significance.
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Chapter IV
Results
Description of the Sample
In total, 53 patients received a free influenza immunization and the associated
MTM services, if applicable. All patients participated in the survey. However, one survey
was omitted from the analysis due to insufficient completeness. Thus, the effective
response rate for the survey was 98% (52 of 53).
Table 2 contains a description of the sample based on characteristics obtained
through the demographic questions from the survey. 85% of patients in the study were 45
years of age or older. Considering gender and ethnicity, the majority was female and
Caucasian. Over one-third of patients (36.7%) reported a total household income below
$25,000. 39.4% also reported having no form of health insurance.
Table 3 contains descriptions of medication use as reported by patients. The
patients reported taking an average of 3.6 prescription medications per day. While 60.6%
of patients claimed to have a method of remembering medications, approximately half
(48.9%) experienced forgetfulness and non-adherence when taking their prescriptions.
Furthermore, 70% visit a pharmacy with a frequency of at least once per month.
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Table 2: Demographic Characteristics
Age

(%)

18 – 24

3

25 – 34

0

35 – 44

12.1

45 – 65

63.6

65+

21.2

Gender
Male

30.3

Female

69.7

Ethnicity
Caucasian

93.9

African American

6.1

Hispanic

0

Asian

0

Other

0

Total Household Income
< $15,000

26.7

$15,000 - $24,999

10

$25,000 - $34,999

13.3

$35,000 - $49,999

16.7

$50,000 - $74,999

20

> $75,000

13.3

Health Insurance

!

Medicare

6.1

Medicaid

0

Private provider

30.3

Medicare + Private

12.1

No insurance

39.4
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Table 3: Characteristics of prescription medication use
Mean number of prescription
medications per day

3.6

Method of remembering medications

(%)

Yes

60.6

No

39.4

Forget to take medications
Yes

48.5

No

51.5

Frequency of pharmacy visits
Once a month

53.3

More than once a month

16.7

Less than once a month

26.7

Unsure

3.3

Objective 1: Determine patients’ perceptions of the roles of pharmacists, including trust
in pharmacists as clinical providers
The majority of respondents indicated they would visit a physician when
experiencing medication problems, as shown in Table 4. However, 36.3% indicated they
would visit a pharmacist either alone or in conjunction with other health care providers
for resolution of medication issues. Interestingly, over 20% of patients would visit
multiple health care providers for help with medication problems.
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Table 4: Who would you visit if you had a problem with
your medications?
Doctor

51.5%

Pharmacist

21.2%

Nurse

3%

Nurse practitioner

3%

More than 1 of the above

21.2%

A clear majority believed pharmacists have the ability to manage and resolve
medication related problems (Table 5). While patients preferred to visit a physician for
medication problems, the belief in pharmacists’ capability to handle and resolve
medication issues suggests patients would be open to receiving increased help from
pharmacists.
Table 5: Do you believe that pharmacists can help manage
and fix problems with your medications?
Yes

90.6%

No

9.4%

For the question on trust in pharmacists shown in Table 6, responses were
analyzed from all patients who answered the question (n=50) because trust in pharmacists
includes more factors than only prescription medication use. Every patient in the study
indicated trust in pharmacists, which is consistent with prior Gallup polls placing
pharmacists among the most highly trusted professions.43 A follow-up question inquired
about trust in pharmacists pertaining to the Medication Therapy Review.
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Table 6: In general, do you trust pharmacists?
Yes

100%

No

0%

A strong majority trusted pharmacists as providers of MTR services (Table 7). In
this case, those who answered the question (n=32) already received MTM services during
the intervention. Because patients experienced first hand the provision of a Medication
Therapy Review, the beliefs presented indicate trust in pharmacists as clinical providers
of medication management services. Thus, based on the descriptive responses in this
section, patients did trust pharmacists both overall and for provision of clinical services.
Finally, qualitative themes were gathered from an open-ended question on expectations
regarding pharmacists. The most reported expectation of pharmacist included the
traditional roles of dispensing and counseling (Table 8).
Table 7: Do you trust pharmacists to provide a Medication
Therapy Review?
Yes

96.9%

No

3.1%

Table 8: When you visit a pharmacy, what do you expect the pharmacist to do?
Fill prescriptions

Most frequent theme (n=14)

Counsel and provide knowledge on side effects

Second (n=9)

Answer medication related questions

Third (n=8)

Prevent medication interactions / Friendy

Least frequent (n=2)

Project friendly attitude

Least frequent (n=2)
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Objective 2: Determine patients’ awareness of Medication Therapy Management
Survey results indicate low awareness of MTM. Two out of three patients (66.7%)
did not know about Medication Therapy Management prior to the service event.
However, approximately half of the sample (48.5%) reported non-adherence as a
medication issue. While many patients could benefit from MTM, particularly for
adherence, the majority simply was not aware this clinical pharmacy service existed
(Table 9).

Table 9: Have you heard of the term Medication Therapy
Management before today?
Yes

33.3%

No

66.7%

Objective 3: Determine patients’ perceived benefit and satisfaction from the MTM
services received during the intervention.
Three out of four patients (75%) perceived benefit after going through the MTM
services provided at the intervention, as shown in Table 10. The positive feedback from
patients suggests satisfaction with MTM even though most patients came into the study
without prior awareness of these services. Though only 42% reported finding new ways
to remember medication and increase adherence as a result of the service (Table 11),
most patients (60.6%) indicated already having methods to remember medications before
participating in the event. Further analysis between reported non-adherence and MTM
helpfulness was conducted for Objective 4.
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Table 10: Do you think you will benefit from the
Medication Therapy Review?
Yes

75%

No

25%

Table 11: Did the Medication Therapy Review help you
find new ways to remember to take your medicine?
Yes

42%

No

58%

Responses for the Likert-type items shown in Table 12 included a range from 1
(strongly disagree) to 5 (strongly agree). Overall, the Likert-type scores showed positive
perceptions regarding the MTM services. The highest mean reflected perceived value in
the Personal Medication Record given to each patient. About 64% of the sample reported
increased understanding of accurate medication use as a result of the MTM intervention.
Four out of five patients (80%) found benefit in the conjointly provided MTM and
influenza immunization. Finally, 73% indicated willingness to visit their community
pharmacy for further MTM services in the future. Finally, qualitative themes were
gathered from an open-ended question on specific assistance provided by the MTM. The
percentages of patients reporting the different themes are listed in Table 13.
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Table 12: Likert-type responses rating satisfaction with MTM
Question

Mean

Median

The Medication Therapy Review helped me
understand how to properly use my prescription
and over-the-counter medicines.

3.97

4

Std.
Deviation
1.06

Getting my flu shot and Medication Therapy
Review at the same time is a beneficial service.

4.36

5

1.14

I think the wallet card medication list provided
by the pharmacist is a valuable tool.

4.64

5

0.99

I would visit my local community pharmacy to
receive Medication Therapy Reviews in the
future.

4.12

5

1.26

Most patients reported the counseling and information on side effects during
MTM as beneficial. However, over 20% specifically noted the pharmacist’s assistance
with increasing medication adherence. Isolated themes included cost management,
choosing appropriate medications, decreasing complications, smoking cessation, and
assessment of blood sugar and blood pressure.
Table 13: Can you please list some ways the Medication
Therapy Review helped you?

!

Counseling and knowledge of side effects

44.4%

Increase remembrance for taking
medications

22.2%

Pharmacist knows what medications to
prescribe

5%

Decrease medication complications

5%

Ensure complete control of medications

5%
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Provide assistance with medication cost

5%

Smoking cessation services

5%

Assess blood sugar, blood pressure, and
family history

5%

Objective 4: Compare patients’ non-adherence with MTM helpfulness.
Table 14 contains the results of a Fishers Exact statistical significance test used to
analyze 2x2 contingency tables. For this objective, the test compared the patients’
response to non-adherence based on forgetfulness (Question 3) and MTM helpfulness in
remembering new medications (Question 14).

Yes
Forgetful
No
Total

Table 14: Forgetfulness vs. Helpfulness
MTM Helpful
Yes
No
Count
11
4
% within Forgetful
73.3%
26.7%
Count
2
14
% within Forgetful
12.5%
87.5%
Count
13
18
% within Forgetful
41.9%
58.1%

Total
15
100.0%
16
100.0%
31
100.0%

According to the Fisher’s Exact Test, there was a statistically significant
difference between two groups (p < 0.01). Thus, those who reported “yes” to the question
on forgetfulness were more likely to find the MTM service helpful (73.3% vs. 12.5%,
respectively).
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Objective 5: Compare patients’ non-adherence and DRAW tool efficacy.
Table 15 contains the results of McNemar’s Test and Cohen’s kappa coefficient
as statistical measure of agreement between categorical items. For this objective, the test
compared patients’ responses to non-adherence based on forgetfulness (Question 3) and
the DRAW tool results (problem identified vs. no problem identified).

Forgetful

Total

Table 15: Forgetfulness vs. DRAW Tool
DRAW
Yes
No
Count
10
6
Yes
% of Total
30.3%
18.2%
Count
6
11
No
% of Total
18.2%
33.3%
Count
16
17
% of Total
48.5%
51.5%

Total
16
48.5%
17
51.5%
33
100.0%

Based on the Kappa value (0.27, p=0.12), there was not statistically significant
agreement between the two approaches to detect potential problems with non-adherence.
However, the results of the McNemar test (p > 0.99) suggest there is insufficient evidence
to state that the proportion of patients rated as non-adherent is different between the
DRAW tool and the forgetfulness question. A total of 30.3% of the responses indicated
agreement between non-adherence and DRAW problem, and 33.3% indicated agreement
in adherence and no DRAW problem. Thus, the overall level of agreement was 63.6%.
Based on this analysis, no definitive statements can be made concerning the concordance
or discordance of these two approaches.
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Chapter V
Discussion and Implications
The primary purpose of this research project was to evaluate the current
perceptions on adherence targeted medication therapy management as part of the
influenza immunization administration workflow as reported by patients at a clinic for the
medically underserved in Southaven, Mississippi. No prior studies in Mississippi provide
a review of conjointly provided influenza immunizations and Medication Therapy
Management.

Limitations
One limitation in this study was the small sample size. Despite radio recruitment
and advertising at the free clinic, only 53 subjects participated in the event even though
90 free influenza immunizations were available for the project. Of those 53 subjects, only
a smaller portion (n=33) took prescription medications. Statistical analysis of the study
was at risk for failing to recognize statistical significance (Type II error). Thus, due to the
small sample size, the ability to generalize the results discovered in the research is
limited.
Secondly, any potential generalizations must consider the low diversity in patient
demographics. The strong majority of patients who received the clinical services fell into
the Caucasian ethnic category and female gender category.
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Finally, the study did not ask the patients to distinguish between student
pharmacists and registered pharmacists. It is unknown how the patients would distinguish
perceptions between student pharmacists and pharmacy practitioners with greater levels
of experience providing MTM services. Also, the variation in quality between the levels
of service provided by different students was not taken into account. However, the
student pharmacists used clearly defined MTM tools such as DRAW and completed
MTM training prior to the intervention. Therefore, it is reasonable to believe the level of
service provided by the student pharmacists was adequate or better.

Discussion and Implications
The patients in the study indicated generally favorable perceptions regarding the
clinical services they received, as indicated in Table 12. A clear majority trusted
pharmacists as providers of clinical services. While most qualitative expectations of
pharmacists centered on dispensing medications, respondents affirmed pharmacists’
ability to manage and resolve medication related problems. Based on the survey, most
patients would return for further MTM visits in the future. Although limited by small
sample size and its exploratory nature, the preliminary results of this study suggest that
pharmacy practitioners in the Mississippi Delta and other rural locations might expect
positive attitudes from patients engaged in clinical pharmacy services. The sustainability
of MTM implementation is also supported by the patient’s willingness to seek additional
MTM in the future.
While survey results indicate relatively low awareness of MTM, a significant
number of patients experienced medication adherence issues. The DRAW tool was
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heavily focused on maintaining or increasing adherence. It follows that patients
experiencing difficulty with adherence are prime candidates for adherence-targeted MTM
services, as used in this study. Indeed, from the results obtained through the survey,
patients who reported non-adherence due to forgetfulness reported greater benefit the
MTM intervention than patients who did not report any forgetfulness.
The findings of this study relate to the use of pharmacist administered influenza
immunizations in that most patients taking prescription medications attempted to obtain
an influenza immunization every year. Many patients also visited their community
pharmacy once per month, if not more often. Community pharmacies that offer and
advertise influenza immunizations might consider the interaction with patients during the
flu shot as an optimal opportunity to provide MTM and adherence services.
Based on the findings of this study, the following recommendation for use within
community pharmacy settings may be considered. During the brief waiting period
following the immunization, a pharmacist could initiate dialogue with the patient by
offering to discuss the patients’ medications. If the patient indicates willingness to talk
about their medications, the pharmacist might ask: “Do you feel like you have too many
medications or too many doses per day?” or “Do you sometimes forget to take your
medication on routine days?” Based on the patient’s response to these questions, the
pharmacist should consider using the DRAW Tool to further engage with the patient and
provide recommendations such as adherence or memory aids, daily alarms, specialized
packaging, medication calendars and medication synchronization. The pharmacist could
also consider providing a Personal Medication Record, as many patients in this study
found the PMR quite beneficial. Further, another benefit of using the DRAW tool in a
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pharmacy practice setting where more than one pharmacist or student pharmacist
provides immunizations is that all patients would receive consistent adherence
interventions due to the structured nature of the conversation with the patient.
However, if the patient does not indicate any forgetfulness or problems managing
doses, adherence-focused MTM is less likely to provide substantial benefits for the
patient. Some patients indicated no forgetfulness, but the student pharmacists still
uncovered adherence problems with DRAW tool. Forgetfulness is only one aspect of
medication adherence problems. Other issues including medication side effects and cost
may also affect adherence. The other causes for non-adherence might contribute to the
lack of agreement found in Table 15. MTM services related to medication cost and side
effects might provide additional benefits for these patients.
While influenza immunizations are a prime opportunity to engage patients, this is
not the only occasion for pharmacists to offer clinical services. Pharmacists could also
use routine pneumonia and shingles vaccines as a chance to offer MTM. Likewise,
pharmacists also meet with patients for other services such as glucose monitoring and
blood pressure check-ups. When providing clinical services, pharmacists have the
opportunity raise awareness of MTM and potentially improve health outcomes by
increasing medication adherence.

Future Research Exploration
This research project only considered the perceptions reported by patients
undergoing this intervention. However, it did not collect information on how students
perceived these services. Further exploration may inquire about the impact of pharmacy
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practice interventions on students providing the services. Another interesting and
unexpected finding was that over 20% of patients reported seeking medication assistance
from multiple health care providers. Research regarding perceptions of inter-professional
management of medication, especially in rural environments use may be an additional
avenue of investigation in the future.
In the only omitted survey, the subject was Hispanic and communicated primarily
in Spanish. In future studies, having a survey already translated into Spanish could
provide an alternate method for obtaining surveys from participants who are not fluent in
English. Also, this study did not evaluate patients’ willingness to pay for the services
received. More research is likely necessary on the financial opinions of patients and
potential compensation methods for pharmacists.
Finally, the intervention in this study combined the influenza immunization and
MTM. Conducting future research with groups receiving only flu shots and only MTM
versus the combined group would allow for in depth analysis of how patients in the
Mississippi Delta distinguish between the benefits of these services.
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APPENDIX A: SURVEY INSTRUMENT
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APPENDIX B: INTERVENTION FLOW CHART
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APPENDIX C: RADIO RECRUITMENT
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You!are!invited!to!a!community!health!fair!at!Desoto!Health!and!Wellness!in!
Southaven!on!Saturday!November!2!from!10am!to!2pm.!This!event!is!hosted!by!the!
University!of!Mississippi!School!of!Pharmacy!and!Funderburk’s!Pharmacy.!For!the!
first!90!people,!18!years!and!older,!we!are!providing!FREE!flu!shots!!Also,!don’t!
forget!to!bring!your!prescription!and!over!the!counter!medicine!bottles!with!you!for!
a!free!medication!review.!Please!come!Saturday,!November!2,!at!Desoto!Health!and!
Wellness!located!at!8889!Northwest!Dr.!in!Southaven.!Call!662Q393Q9848!for!more!
information.!!
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APPENDIX D: PARTICIPATION SCRIPT

!
Hello,!I’m!a!student!at!the!University!of!Mississippi.!Would!you!be!willing!to!take!a!
brief!survey!regarding!the!medication!management!services!you!just!received?!!
!
If!“YES”:!Thank!you.!Are!you!at!least!18!years!old?!
!
If!“YES”:!Great,!please!complete!the!survey!and!place!it!in!the!collection!envelope.!
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